A multicenter prospective study for the utility of a target sample check illuminator (TSCI), concerning the detection of target specimens in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) samples for pancreatic masses and lymph node tumors.

A multicenter prospective study for the utility of a target sample check illuminator (TSCI), concerning the detection of target specimens in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) samples for pancreatic masses and lymph node tumors. - A multicenter prospective study for the utility of a target sample check illuminator

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023349

Enrollment

Registered

2016-07-27

Start date

2016-07-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic masses and lymph node tumors.

Interventions

We will perform endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for pancreatic masses and lymph node tumors.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Age of patients at start of the trial is 20 years or older 2) Patients with digestive malignant tumors with the need of pathological diagnosis before treatment

Exclusion criteria

Exclusion criteria: 1) People who have taken chemotheraphy for malignant tumors within one month before the start of the trial. 2) Patients who have had other cancers 3) Patients who are taking anticoagulant or antithrombotic drugs 4) Women who are pregnant or are possibly pregnan

Design outcomes

Primary

Measure	Time frame
The detection rate for target specimens by viewing only.	—

Countries

Japan

Contacts

Public ContactKazuya Matsumoto

Tottori University School of medicine Division of Medicine and Clinical Science

ayano0620@hotmail.co.jp0859-38-6527

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026